2,7-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 97%, 1g

3-Bromo-5-iodobenzotrifluoride, 97.0%, 10g

4-(5-Bromopyrimidin-2-yl)morpholine, 97.0%, 25g

6-Nitro-1H-benzoimidazole-2-thiol, 97.0%, 1g

Nitrate de chrome(III) nonahydraté, min 98%, pa, 500 g, emballage plastique.

2-(2,4-Dichlorophenoxy)ethan-1-amine, 98%, 5g

tert-Butyl (4-bromothiophen-3-yl)carbamate, 95%, 100mg

Tert-butyl 4-(but-3-yn-1-yl)piperazine-1-carboxylate, 98%, 5g

7-Bromobenzo[d]isoxazol-3-amine, 95.0%, 250mg

Thiazol-5-ylmethyl ((2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate, 95%, 25g

4-(Bromomethyl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-indazole, 98%, 25g

2-(1-Hydroxyethyl)pyrimidin-5-ol, 95+%, 500mg

sec-Butyl Ether (DL- and meso- mixture) (stabilized with HQ)>97.0%(GC)5mL